Clinical Trial Update: ROTATEQ Reexamination Study (V260-037)

View source ↗

Summary

ROTATEQ reexamination study (NCT01074242) has completed, and results were posted on March 27, 2014. The study evaluated the Rotavirus vaccine, live, tetravalent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• RotaTeq (rotavirus vaccine, pentavalent)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Gastroenteritis Rotavirus | Status: COMPLETED | Results posted: 2014-03-27